thymosin beta-4 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-22. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
| Property | Value | Notes |
|---|---|---|
| Name type | Commercial trade name | Not a systematic chemical identifier |
| Parent peptide | Thymosin beta-4 | 43-residue natural peptide |
| Common fragment sequence | LKKTETQ | Maps to part of the actin-binding region |
| Molecular size class | Roughly 0.8-1.0 kDa | Depends on exact fragment and terminal modification |
| Regulatory status | Prohibited in sport | Grouped with peptide hormones in many frameworks |
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
== Etymology == The word slave was borrowed into Middle English through the Old French esclave which ultimately derives from Byzantine Greek σκλάβος (sklábos) or ἐσκλαβῆνος (esklabḗnos). According to the widespread view, which has been known since the 18th century, the Byzantine Σκλάβινοι (Sklábinoi), Ἐσκλαβηνοί (Esklabēnoí), borrowed from a Slavic tribe self-name *Slověne, turned into σκλάβος, ἐσκλαβῆνος (Late Latin sclāvus) in the meaning 'prisoner of war slave', 'slave' in the 8th/9th century, because they often became captured and enslaved. However this version has been disputed since the 19th century. An alternative contemporary hypothesis suggests that Medieval Latin sclāvus via *scylāvus derives from Byzantine σκυλάω (skūláō, skyláō) or σκυλεύω (skūleúō, skyleúō) with the meaning "to strip the enemy (killed in a battle)" or "to make booty / extract spoils of war". This version has been criticized as well.
S2CID 17336375. Wickramasinghe, N. C. (2010). "The astrobiological case for our cosmic ancestry". International Journal of Astrobiology. 9 (2): 119–129. Bibcode:2010IJAsB...9..119W. doi:10.1017/S1473550409990413. S2CID 13978227. Wickramasinghe, N.C.; Wallis, J.; Wallis, D.H.; Schild, R.E.; Gibson, C.H. (2012). "Life-bearing planets in the solar vicinity". Astrophysics and Space Science. 341 (2): 295–9. Bibcode:2012Ap&SS.341..295W. doi:10.1007/s10509-012-1092-8. S2CID 120484953. Chandra Wickramasinghe, A Journey with Fred Hoyle: The Search for Cosmic Life, World Scientific Publishing, 2005, ISBN 981-238-912-1 Janaki Wickramasinghe, Chandra Wickramasinghe and William Napier, Comets and the Origin of Life, World Scientific Publishing, 2009, ISBN 981-256-635-X Chandra Wickramasinghe and Daisaku Ikeda, Space and Eternal Life, Journeyman Press, 1998, ISBN 1-85172-060-X
== History == Alazocine was one of the early members of the benzomorphan family of opioid analgesics to be investigated. It was first described in the scientific literature in 1961. Its development resulted from nalorphine (N-allylnormorphine), a potent analgesic and opioid antagonist with similar pharmacology which had been introduced in the mid-1950s. Alazocine was found to produce strong psychotomimetic effects in humans, and it was not further developed for clinical use. Subsequently, other benzomorphans, such as pentazocine (an N-dimethylallylbenzomorphan), cyclazocine (an N-cyclopropylmethylbenzomorphan), and phenazocine (an N-phenylethylbenzomorphan), were developed, and some have been marketed for use as analgesics. The sigma σ1 receptor was named in 1976 and (+)-alazocine was described as its prototypical ligand. The receptor was initially thought to be an opioid receptor, and then was confused with the NMDA receptor for a time, but was ultimately distinguished from them both. The psychotomimetic effects of alazocine and the other benzomorphans were initially attributed incorrectly to agonism of the σ1 receptor; subsequent research established that the effects are in fact caused by agonism of the κ-opioid receptor and/or antagonism of the NMDA receptor.
Sources: en.wikipedia.org
=== Galactose metabolism === Lactose, or milk sugar, consists of one molecule of glucose and one molecule of galactose. After separation from glucose, galactose travels to the liver for conversion to glucose. Galactokinase uses one molecule of ATP to phosphorylate galactose. The phosphorylated galactose is then converted to glucose-1-phosphate, and then eventually glucose-6-phosphate, which can be broken down in glycolysis.
According to an Afghan media outlet, Pakistani aircraft have repeatedly patrolled Afghan airspace over the past two months, promoting Taliban forces to fire at them, which in some cases has resulted in casualties and damage to Afghan civilians. Two TTP militants and a policeman were killed in a clash in Lakki Marwat. On 21 April, Pakistani military claimed to have carried out an operation in Khyber District killing 22 TTP militants while a child was also killed in the crossfire. On 22 April, local Afghan sources reported that Pakistani forces carried out mortar strikes targeting Asadabad, provincial capital of Kunar province. Earlier, local Afghan sources said that the villages of Kochi, Shahbaz and Koremar in Kunar province were targeted by artillery strikes carried out by Pakistani forces. Elsewhere, border areas of Paktika province were also subjected to cross border shelling by Pakistani forces, according to local Afghan sources. No casualties were reported in these attacks, and Taliban officials did not comment on them. On 24 April, TTP attacked a police station in Dera Ismail Khan District using heavy weapons damaging the station and nearby buildings. On 26 April, three civilians were wounded in a Taliban artillery attack at Zalulkhel area in South Waziristan. In response, Pakistan claimed to have destroyed Taliban firing positions and foiled infiltration attempts. On 27 April, seven people were killed and 85 others were injured in Pakistani strikes in Kunar province, including a strike on the Sayed Jamaluddin Afghani University in the provincial capital of Asadabad.
The chronic kidney disease of the cat (CKD or CNE)—also called chronic renal insufficiency (CRI or CNI) or chronic renal failure (CRF) in the older literature—is an incurable, progressive disease characterized by a gradual decrease in the nephrons and thus to a decreasing function (insufficiency) of the kidneys. It is one of the most common causes of death in older domestic cats. In current literature, the term "kidney disease" is preferred to the term "renal insufficiency" because the disease initially progresses without any measurable decline in kidney function. Due to the different type of diet and the resulting metabolic peculiarities, the clinical picture and treatment sometimes differ significantly from chronic renal failure in humans. Chronic kidney disease occurs in cats as a result of inflammation of the renal tubules and the renal interstitial tissue without an identifiable cause (idiopathic tubulointerstitial nephritis). The main symptoms are a reluctance to eat, increased drinking, increased urine output, fatigue, vomiting and weight loss. Chronic kidney disease in cats is divided into four main stages based on the creatinine concentration in the blood plasma, which are further subdivided according to the protein-creatinine quotient in the urine and blood pressure. Treatment is mainly based on reducing the protein and phosphate content of the diet to the basic requirement ("renal diet").
SR-16435 is a drug which acts as a potent partial agonist at both the μ-opioid receptor and nociceptin receptor. In animal studies it was found to be a potent analgesic, with results suggestive of reduced development of tolerance and increased activity against neuropathic pain compared to classic μ-selective agonists.
Sources: en.wikipedia.org
Transamination is a chemical reaction that transfers an amino group from an amino acid to an α-keto acid. This process mainly takes place in the liver. In the liver, amino groups from different amino acids are transferred to α-ketoglutarate to form glutamate. In the mitochondria, glutamate is deaminated and toxic ammonium enters the urea cycle for excretion. Another site of transamination is the skeletal muscles. In the skeletal muscles, amino groups are transferred to pyruvate, forming alanine. Alanine carries nitrogen to the liver through the glucose–alanine cycle. In biochemistry, the process occurs extensively during amino acid synthesis and is catalyzed by transaminases (aminotransferases), which requires the cofactor pyridoxal phosphate (PLP), and an α-keto acid as the acceptor of the amino group. α-ketoglutarate acts as the predominant amino-group acceptor and produces glutamate.
means "that amount of energy lost as a result of work". Thus one can state the amount of internal energy possessed by a thermodynamic system that one knows is presently in a given state, but one cannot tell, just from knowledge of the given present state, how much energy has in the past flowed into or out of the system as a result of its being heated or cooled, nor as a result of work being performed on or by the system. Entropy is a function of the state of a system which tells of limitations of the possibility of conversion of heat into work. For a simple compressible system, the work performed by the system may be written:
American Ornithologists’ Union Committee on Bird Collections ORNithological Information System (ORNIS) Type-specimens in 3D Extinct specimens in 3D (National History Museum of the Netherlands — Naturalis) Museum handbook Inventory of major European bird collections F.D. Steinheimer The whereabouts of pre-nineteenth century bird specimens Zool. Med. Leiden 79-3 (5), 30-ix-2005, 45-67.— ISSN 0024-0672. ebeac electronic index of bird collections
=== Oral syringes === An oral syringe is a measuring instrument used to accurately measure doses of liquid medication, expressed in millilitres (mL). They do not have threaded tips, because no needle or other device needs to be screwed onto them. The contents are simply squirted or sucked from the syringe directly into the mouth of the person or animal. Oral syringes are available in various sizes, from 1–10 mL and larger. An oral syringe is typically purple in colour to distinguish it from a standard injection syringe with a luer tip. The sizes most commonly used are 1 mL, 2.5 mL, 3 mL, 5 mL and 10 mL.
=== 2010–2012: Early career === Melksham was recruited by the Essendon Football Club with their first selection and tenth overall in the 2009 national draft. The Age journalist, Will Brodie, predicted he would debut and play in the midfield early in the season and he made his debut in the twenty point win against Carlton at the Melbourne Cricket Ground in round three. He played the next two matches before he was omitted for the round six match against Hawthorn at the Melbourne Cricket Ground; he returned the next week for the three-point loss against Port Adelaide at Etihad Stadium where he kicked his first AFL goal. He was rewarded with the round eight nomination in the AFL Rising Star after he recorded fourteen possessions, three clearances, three tackles and a goal in the twelve point win against St Kilda at Etihad Stadium. He missed the round ten match against the Western Bulldogs after he sprained his ankle during the thirty-five-point win against Richmond the week before, he returned the next week for the nine-point loss against Sydney at the Sydney Cricket Ground. He played the next four out of five matches, missing the round fifteen match against Melbourne due to being rested, before he was dropped for the round seventeen match against North Melbourne at Etihad Stadium.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.
Published work usually examines actin binding, cell migration and tissue repair endpoints in cell and animal models. Findings are generally described as preliminary, and controlled human data remain limited.
Because TB-500 is a trade name rather than a chemical identifier, different vendors and papers may attach it to different fragment lengths. Checking the stated sequence is the practical way to resolve the ambiguity.
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.